Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its ...
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Apr 24, 2024 • 7 minute read Article content PARIS, FRANCE, 24 April 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its …